Salud financiera de hoja de balance de Qiagen
Salud financiera controles de criterios 6/6
Qiagen tiene un patrimonio de accionistas total de $3.8B y una deuda total de $1.6B, lo que sitúa su ratio deuda-patrimonio en 42.2%. Sus activos y pasivos totales son $6.1B y $2.3B respectivamente. El BAIT de Qiagen es de $445.2M, por lo que su ratio de cobertura de intereses es de -17.4. Tiene efectivo e inversiones a corto plazo que ascienden a $1.1B.
Información clave
41.8%
Ratio deuda-patrimonio
US$1.50b
Deuda
| Ratio de cobertura de intereses | -15x |
| Efectivo | US$893.13m |
| Patrimonio | US$3.60b |
| Total pasivo | US$2.21b |
| Activos totales | US$5.81b |
Actualizaciones recientes sobre salud financiera
Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly
Mar 20
These 4 Measures Indicate That Qiagen (NYSE:QGEN) Is Using Debt Reasonably Well
Dec 08Qiagen (NYSE:QGEN) Seems To Use Debt Quite Sensibly
Sep 04Is Qiagen (NYSE:QGEN) Using Too Much Debt?
May 23Qiagen (NYSE:QGEN) Seems To Use Debt Quite Sensibly
Feb 15We Think Qiagen (NYSE:QGEN) Can Stay On Top Of Its Debt
Oct 31Recent updates
Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly
Mar 20Calculating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)
Feb 13Qiagen N.V.'s (NYSE:QGEN) Price Is Out Of Tune With Earnings
Jan 23These 4 Measures Indicate That Qiagen (NYSE:QGEN) Is Using Debt Reasonably Well
Dec 08An Intrinsic Calculation For Qiagen N.V. (NYSE:QGEN) Suggests It's 41% Undervalued
Oct 24Qiagen: No Upsides Slated In FY'23 In Core Business Lines, Reiterate Hold
Sep 09Qiagen (NYSE:QGEN) Seems To Use Debt Quite Sensibly
Sep 04Calculating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Jul 17Qiagen: Major Asset Growth Needed In Post-Covid World
Jun 22Is Qiagen (NYSE:QGEN) Using Too Much Debt?
May 23Calculating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Apr 18Qiagen (NYSE:QGEN) Seems To Use Debt Quite Sensibly
Feb 15Qiagen: Strong Q4, Derisked Portfolio, Fairly Valued
Feb 14Qiagen Non-GAAP EPS of $0.53, revenue of $498M, FY23 guidance initiated
Feb 07If EPS Growth Is Important To You, Qiagen (NYSE:QGEN) Presents An Opportunity
Jan 18Qiagen, Helix partner to advance NGS companion diagnostics in hereditary diseases
Jan 06A Look At The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Jan 04Qiagen's test gets FDA nod for companion diagnostic to Mirati's cancer drug Krazati
Dec 13Qiagen Non-GAAP EPS of $0.53 beats by $0.08, revenue of $500M beats by $17.91M
Nov 07We Think Qiagen (NYSE:QGEN) Can Stay On Top Of Its Debt
Oct 31Qiagen stock down after BHF downgrades rating to Neutral
Oct 10Calculating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Oct 04Qiagen to develop companion diagnostic for Neuron23's Parkinson's disease drug candidate
Sep 14Does Qiagen (NYSE:QGEN) Deserve A Spot On Your Watchlist?
Aug 25Is Qiagen (NYSE:QGEN) Using Too Much Debt?
Jul 28Qiagen Fails To Justify Inclusion In Long-Biased, Balanced Macro Portfolio
Jul 15Is Qiagen N.V. (NYSE:QGEN) Trading At A 36% Discount?
Jun 29Does Qiagen (NYSE:QGEN) Deserve A Spot On Your Watchlist?
May 26Is Qiagen (NYSE:QGEN) A Risky Investment?
Apr 29Are Investors Undervaluing QIAGEN N.V. (NYSE:QGEN) By 31%?
Mar 30Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($2.1B) de QGEN superan a sus pasivos a corto plazo ($1.1B).
Pasivo a largo plazo: Los activos a corto plazo de QGEN ($2.1B) superan a sus pasivos a largo plazo ($1.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (14.5%) de QGEN se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de QGEN ha pasado de 83.2% a 42.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de QGEN está bien cubierta por el flujo de caja operativo (28.6%).
Cobertura de intereses: QGEN gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.